PD Dr. Carolina Rosswog

Education and Professional Career

Academic education
2008-2009: Medical Intern in Quito, Ecuador (Hospital Baca Ortiz and Hospital Metropolitano) and Bern, Switzerland (Inselspital)
2003-2009: Medical School, Philipps-University Marburg; University of Barcelona, Spain

Scientific degrees 
2024: Post-doctoral lecture qualification
2011: MD thesis, Philipps-University Marburg
2009: Graduation from Medical School, University of Marburg

Research activities/ Scientific career 
since 2025: Advanced Clinician Scientist Program of the Medical Faculty, University of Cologne (50% research, 50% clinics) 
since 2024: Research group Leader in the Department of Experimental Pediatric Oncology   
2023-2025: Clinician scientist fellowship, Department of Pediatrics, University Hospital Cologne (50% research, 50% clinics)
2022-2023: Köln Fortune Habilitation Fellowship (50% research, 50% clinics) 
2021-2022: Gusyk Clinician Scientist Fellowship (50% research, 50% clinics) 
2018-2020: Fellowship Else-Kröner Fresenius Foundation, “Clonal evolution of cancer” (100% research) 
since 2013: Post-doctoral fellow, Department of Experimental Pediatric Oncology Cologne

Clinical activities/ Scientific career 
since 2025: Senior consultant physician, Department of Pediatric Oncology and Hematology, University Hospital Cologne
2018-2025: Resident physician, Department of Pediatric Oncology and Hematology, University Hospital Cologne 
2011-2017: Resident physician, Department of Pediatrics, University Hospital Cologne
2010-2011: Resident physician, Department of Pediatric Surgery, University Hospital Bern, Switzerland

Awards, Distinctions and Scientific Activities

Awards 
2023: Adalbert-Czerny-Award, German Society of Pediatrics and Adolescent Medicine 
2022: Erna Brunner Award, Stiftung des Fördervereins für krebskranke Kinder Tübingen 
2021: Best publication award of the Medical Faculty, University of Cologne 
2021: Kind-Philipp Award for pediatric oncology research, Kind-Philipp Foundation 
2012: Plester Dissertation Award, German Society of Otorhinolaryngology

Memberships 

  • German Society of Pediatrics and Adolescent Medicine (DGKJ), member of the “DGKJ Hochschulkommission”
  • German Society of Pediatric Oncology and Hematology (GPOH), member of the Neuroblastoma National Study Committee
  • International Society for Pediatric Oncology Europe Neuroblastoma (SIOPEN), co-chair of the New Drug Development (NDD) Committee, member of the Steering Committee of the Biology Committee
  • New Approaches to Neuroblastoma Therapy (NANT)
  • International Neuroblastoma Risk Group Task Force (INRG), co-chair of the Data Fields Committee
  • Advances in Neuroblastoma Research Association (ANRA), member of the European Advisory Board

Publications

Link to PubMed